ARCHIVES

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

This article is from The Cancer Letter archive.

Vol. 30 No. 9 | September 28, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Weiner Elected President-Elect of AACI

February 15, 2013

DOD To Reimburse Care On Clinical Trials In Three-Year Deal

February 9, 1996

ASCO Publishes Guidelines For Dosing Chemotherapy Correctly in Obese Patients

April 27, 2012

ONS Membership Still Climbing, Soars over 15,000

June 23, 1989

NCI Programs: Functional Imaging Centers Grant Program Approved By Advisors

December 11, 1998

Ceritinib Demonstrates 58% ORR, 7-month PFS in ALK+ NSCLC

March 28, 2014